Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein

NCT01827722 is registered in ClinicalTrials.gov with Valley Retina Institute as lead sponsor.

NCT NCT01827722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein
Lead sponsor
Valley Retina Institute
Phase
Phase 4
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2016
Enrollment
45 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

central retinal vein occlusion, macular edema